AZT — Arcticzymes Technologies ASA Share News
0.000.00%
Last trade - 00:00- NOK1.02bn
- NOK776.49m
- NOK112.62m
Brief: Arcticzymes Technologies Q4 EBITDA Rises To NOK 6.8 Million
Brief: Arcticzymes Technologies Divests Biotec BetaGlucans Subsidiary To Lallemand
Brief: Arcticzymes Q3 Gross Profit Rises To NOK 26.0 Million
Brief: ArcticZymes Enters Into Supply And Distribution Agreement With Simcere Diagnostics
Brief: Arcticzymes Technologies Q2 EBITDA At NOK 27.2 Million
Brief: ArcticZymes Enters Agreement Regarding COVID-19 Vaccine Candidate
Brief: Biotec Pharmacon Subsidiary Arcticzymes Granted NOK 1.6 Mln Funding From Innovation Norway
Brief: ArcticZymes Gets Funding From Innovation Norway
Brief: Biotec Pharmacon Q1 EBITDA Loss Turns To Profit NOK 13.8 Mln
Brief: Biotec Pharmacon Says Co Appoints Dr. Jethro Holter As CEO
Brief: Biotec Pharmacon Q4 EBITDA Rises To NOK 4.6 Million
Brief: Biotec Pharmacon Says Decided To Stop Further Development Of Woulgan And Search For A New Product Owner
Brief: Biotec Pharmacon Says Arne Reinemo And Inger Rydin Resign From Board With Immediate Effect
Brief: Biotec Pharmacon Q3 Group EBITDA Rises To NOK 0.8 Mln
Brief: Biotec Pharmacon Q3 EBITDA NOK 0.8 Million
Brief: Biotec Pharmacon Appoints Jethro Holter As Interim CEO
Brief: Biotec Pharmacon Q2 Gross Profit Improved 42% To NOK 11.6 Mln
Brief: Biotec Pharmacon Q1 EBITDA Loss Narrows To NOK 3.9 Mln
Brief: Biotec Pharmacon Unit Enters Distribution Agreement With Austrian Publilog